http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0008899-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D503-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D503-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-545 |
| filingDate | 1979-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1982-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1982-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0008899-B1 |
| titleOfInvention | Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them |
| abstract | The compounds of-the formula (I):and salts and esters thereof wherein R<sub>1</sub> is a hydrogen atom or a lower alkyl, aryl or aralkyl group, R<sub>2</sub> and R<sub>3</sub> are independantly hydrogen, aryl, aralkyl, lower alkyl or substituted lower alkyl, or R<sub>3</sub> is joined to R, to form a 5- or 6- membered ring and X is S, SO or SO<sub>2</sub>; have been found to be β-lactamase inhibitors and antibacterial agents. Their preparation and use is described. |
| priorityDate | 1978-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 179.